awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44065014-1C63F885-F69C-4DBD-A5F7-B2D14A1BD363
Q44065014-1C63F885-F69C-4DBD-A5F7-B2D14A1BD363
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44065014-1C63F885-F69C-4DBD-A5F7-B2D14A1BD363
Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.
P2860
Q44065014-1C63F885-F69C-4DBD-A5F7-B2D14A1BD363
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44065014-1C63F885-F69C-4DBD-A5F7-B2D14A1BD363
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4d7f4856b4e821db364f618ca87f778af3e72e7a
P2860
Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.